Metraipolis › archive › dc_8d2bb27c6ce0

BrUOG360: A Phase Ib/II Study of Copanlisib in Combination with Rucaparib in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) — Europe PMC PMID:41231232

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41231232
DOI
10.1158/2767-9764.crc-25-0651
License (as archived)
solo-consultazione
Archived
2026-11-08T02:04:18.754Z
SHA-256 of the archived text
3551c85b0edc7aa561a712b6e295111a5e77483b78343d3927542211fe0a1b9e
Stable URL of this page
https://metraipolis.com/documento/dc_8d2bb27c6ce0

How to cite

BrUOG360: A Phase Ib/II Study of Copanlisib in Combination with Rucaparib in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) — Europe PMC PMID:41231232 — Europe PMC (en), https://europepmc.org/article/MED/41231232 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8d2bb27c6ce0 (Metraipolis archive dc_8d2bb27c6ce0, sha256 3551c85b0edc7aa561a712b6e295111a5e77483b78343d3927542211fe0a1b9e)
BibTeX
@misc{dc8d2bb27c6ce0,
  title = {BrUOG360: A Phase Ib/II Study of Copanlisib in Combination with Rucaparib in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) — Europe PMC PMID:41231232},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41231232},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8d2bb27c6ce0; sha256 3551c85b0edc7aa561a712b6e295111a5e77483b78343d3927542211fe0a1b9e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41231232. Agents can read the archived copy with the MCP tool read_document.